Adam K. Simpson, Chief Executive Officer at Icosavax, Inc. (ICVX), sold 15,000 shares at $15.67 ($235K) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($235k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICVX | SELL | 2023-08-01 | $209K | — | Filing → |
| ICVX | SELL | 2023-02-15 | $160K | — | Filing → |
| ICVX | SELL | 2022-12-23 | $1.2M | — | Filing → |